AngioDynamics, Inc.
Medical Devices & Tech
603 Queensbury Ave.
Queensbury, NY 12804 USA
phone: 518-798-1215
fax: 518-798-3625
Symbol ANGO
Exchange Nasdaq
Founded 1988
Employees 249
www.angiodynamics.com
Research Sector Medical Devices & Tech
Summary Description
Minimally invasive procedures to treat peripheral vascular disease.
Management
Vincent Bucci, Director; Howard W. Donnelly, Director; Paul S. Echenberg, Chairman of the Board; Robert E. Flaherty, Director; Jeffrey G. Gold, Director; Eamonn P. Hobbs, President and CEO, Director; Wesley E. Johnson, Director; Dennis S. Meteny, Director; Steve LaPorte, Director
Ownership
Financials Mkt Cap :307


* numbers in thousands

 
Keywords
peripheral vascular disease, pvd, vascular, heart, coronary, image guided, angiographic catheters, hemodialysis catheters, endovascular laser venous system, pta, dilation balloon catheters, thrombolytic, drainage, radiologists, vascular surgeons, varicose

Comment | Printable Version | Nov. 01, 2008
If you work for AngioDynamics, Inc. and want to update this profile, click here

Description
AngioDynamics develops, manufactures and markets therapeutic and diagnostic devices that enable interventional radiologists, vascular surgeons and other physicians to diagnose and treat peripheral vascular diseases (PVD) and other non-coronary diseases.
Products / Services
The company's product line includes angiographic catheters, hemodialysis catheters, endovascular laser venous system products, PTA dilation balloon catheters, image-guided vascular access products, thrombolytic products and drainage products.
Market / Customers
Over 11 million Americans currently suffer from PVD. AngioDynamics sells its products primarily in the United States, Europe and Japan. The sell in the United States through a direct sales force of 45 sales representatives, seven regional sales managers and a vice president of sales. Abroad, they sell in 33 countries through a network of 28 distributors.


2008-11-22-979